Ann: Encouraging data from PTX-200 ovarian cancer trial, page-79

12 months ago IMU had with HER-Vaxx a fantastic ph1 result, despite chemo all patient produced antibodies as designed, 100% safe, top doses huge tumor reduction and yet got hammered down. People expect a 100% instant cure, that's the problem. Correct, current t-cell drugs achieve billions of dollars despite small % success and often huge side effects. The anns is great but market doesn't understand, like IMU.

New trial with higher dose will take time and even if sponsored, market won't wait another year for improved results - that's the sad reality. No idea at what sp level it will close today, could be back in 9s or getting smashed into 7s.

In the US, encouraging means fantastic, in AUS it means crap. IMU and the sh had to learn that the hard way.

I am out for time being, actually surprised it went to mid 9s as there were too many words that are interpreted negatively by those who got no idea that just stopping the cancer progressing is success.

GLTA